| RECONCILIATION OF R&D AND SG&A EXPENSES TO NON-GAAP R&D AND SG&A EXPENSES | ||||||||
| (Unaudited, in thousands) | ||||||||
| Three Months Ending | ||||||||
| June 30, 2020 | ||||||||
| Low | High | |||||||
| R&D and SG&A expense | $ | 60,900 | $ | 64,900 | ||||
| Adjustments to reconcile R&D and SG&A expense to non-GAAP R&D and SG&A expense: | ||||||||
| Stock-based compensation expense | (17,500 | ) | (19,500 | ) | ||||
| Non-GAAP R&D and SG&A expense | $ | 43,400 | $ | 45,400 | ||||
